Bank of New York Mellon Corp - THRESHOLD PHARMACEUTICAL INC ownership

THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 85 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is 1.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of THRESHOLD PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2017$30,000
-28.6%
77,385
+5.8%
0.00%
Q1 2017$42,000
+44.8%
73,137
+10.6%
0.00%
Q4 2016$29,000
-40.8%
66,140
-7.4%
0.00%
Q3 2016$49,000
-12.5%
71,391
-18.8%
0.00%
Q2 2016$56,000
-52.9%
87,965
-66.0%
0.00%
Q1 2016$119,000
-4.0%
258,529
-0.0%
0.00%
Q4 2015$124,000
-88.2%
258,639
-0.0%
0.00%
Q3 2015$1,053,000
-18.1%
258,684
-18.7%
0.00%
Q2 2015$1,286,000
+4.2%
318,282
+4.7%
0.00%
Q1 2015$1,234,000
+44.8%
303,893
+13.5%
0.00%
Q4 2014$852,000
-12.3%
267,851
-0.5%
0.00%
Q3 2014$971,000
-56.4%
269,078
-52.1%
0.00%
Q2 2014$2,226,000
+68.4%
562,096
+102.3%
0.00%
Q1 2014$1,322,000
+7.8%
277,819
+5.8%
0.00%
Q4 2013$1,226,000
-50.0%
262,630
-50.1%
0.00%
Q3 2013$2,450,000
+79.2%
526,806
+102.7%
0.00%
Q2 2013$1,367,000259,9090.00%
Other shareholders
THRESHOLD PHARMACEUTICAL INC shareholders Q4 2013
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 625,558$2,540,0001.95%
CG Asset Management LLC 128,000$520,0000.20%
Rotella Capital Management, Inc. 45,364$184,0000.15%
TFS CAPITAL LLC 348,617$1,415,0000.14%
Rhenman & Partners Asset Management AB 201,537$818,0000.14%
FORTALEZA ASSET MANAGEMENT INC/ 59,180$240,0000.14%
Baker Brothers Advisors 2,925,519$11,878,0000.10%
FEDERATED HERMES, INC. 3,918,305$15,908,0000.05%
FRANKLIN STREET ADVISORS INC /NC 50,000$203,0000.04%
Princeton Alpha Management LP 26,560$108,0000.02%
View complete list of THRESHOLD PHARMACEUTICAL INC shareholders